Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

Abstract Background Anemia in patients with chronic kidney disease (p-CKDs) may initiate or exacerbate left ventricular hypertrophy (LVH). This study aimed to determine whether treatment using long-acting erythropoietin-stimulating agents (L-ESAs) is independently associated with LVH during the pre-...

Full description

Bibliographic Details
Main Authors: Hiroaki Io, Masahiro Muto, Yu Sasaki, Masanori Ishizaka, Toshiki Kano, Haruna Fukuzaki, Takuya Maeda, Yuki Shimizu, Junichiro Nakata, Yusuke Suzuki
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Nephrology
Subjects:
Renal anemia
Epoetin beta pegol
Left ventricular remodeling
Mean hemoglobin
Hemodialysis
Online Access:https://doi.org/10.1186/s12882-023-03133-1

Internet

https://doi.org/10.1186/s12882-023-03133-1

Similar Items